Xerox Holdings Corporation (XRX)
NASDAQ: XRX · Real-Time Price · USD
4.280
+0.060 (1.42%)
Aug 13, 2025, 10:00 AM - Market open
Verve Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Operating Revenue | 6,038 | 6,070 | 6,695 | 6,900 | 6,817 | 6,796 | Upgrade |
Other Revenue | 136 | 151 | 191 | 207 | 221 | 226 | Upgrade |
| 6,174 | 6,221 | 6,886 | 7,107 | 7,038 | 7,022 | Upgrade | |
Revenue Growth (YoY) | -4.97% | -9.66% | -3.11% | 0.98% | 0.23% | -22.55% | Upgrade |
Cost of Revenue | 4,216 | 4,155 | 4,442 | 4,681 | 4,524 | 4,349 | Upgrade |
Gross Profit | 1,852 | 1,960 | 2,314 | 2,318 | 2,403 | 2,552 | Upgrade |
Selling, General & Admin | 1,561 | 1,617 | 1,715 | 1,748 | 1,629 | 1,854 | Upgrade |
Research & Development | 177 | 191 | 229 | 304 | 310 | 312 | Upgrade |
Operating Expenses | 1,811 | 1,881 | 1,987 | 2,094 | 1,994 | 2,222 | Upgrade |
Operating Income | 41 | 79 | 327 | 224 | 409 | 330 | Upgrade |
Interest Expense | -150 | -119 | -68 | -91 | -96 | -94 | Upgrade |
Interest & Investment Income | 15 | 14 | 16 | 11 | 4 | 14 | Upgrade |
Earnings From Equity Investments | - | - | - | - | - | 4 | Upgrade |
Currency Exchange Gain (Loss) | -3 | -15 | -28 | -13 | -7 | -3 | Upgrade |
Other Non Operating Income (Expenses) | -36 | -6 | -137 | 3 | -3 | 7 | Upgrade |
EBT Excluding Unusual Items | -133 | -47 | 110 | 134 | 307 | 258 | Upgrade |
Merger & Restructuring Charges | -10 | -74 | -167 | -65 | -38 | -93 | Upgrade |
Impairment of Goodwill | -1,058 | -1,058 | - | -412 | -781 | - | Upgrade |
Gain (Loss) on Sale of Assets | 16 | -39 | 39 | 56 | 40 | 30 | Upgrade |
Legal Settlements | - | - | - | - | - | 1 | Upgrade |
Other Unusual Items | -33 | 2 | -10 | -38 | - | 60 | Upgrade |
Pretax Income | -1,218 | -1,216 | -28 | -325 | -472 | 256 | Upgrade |
Income Tax Expense | 204 | 105 | -29 | -3 | -17 | 64 | Upgrade |
Earnings From Continuing Operations | -1,422 | -1,321 | 1 | -322 | -455 | 192 | Upgrade |
Net Income to Company | -1,422 | -1,321 | 1 | -322 | -455 | 192 | Upgrade |
Net Income | -1,422 | -1,321 | 1 | -322 | -455 | 192 | Upgrade |
Preferred Dividends & Other Adjustments | 14 | 14 | 14 | 14 | 14 | 14 | Upgrade |
Net Income to Common | -1,436 | -1,335 | -13 | -336 | -469 | 178 | Upgrade |
Net Income Growth | - | - | - | - | - | -85.81% | Upgrade |
Shares Outstanding (Basic) | 125 | 124 | 149 | 156 | 183 | 209 | Upgrade |
Shares Outstanding (Diluted) | 125 | 124 | 149 | 156 | 183 | 211 | Upgrade |
Shares Change (YoY) | -5.90% | -16.70% | -4.42% | -14.83% | -13.37% | -9.32% | Upgrade |
EPS (Basic) | -11.50 | -10.75 | -0.09 | -2.15 | -2.56 | 0.85 | Upgrade |
EPS (Diluted) | -11.50 | -10.75 | -0.09 | -2.15 | -2.56 | 0.84 | Upgrade |
EPS Growth | - | - | - | - | - | -85.52% | Upgrade |
Free Cash Flow | 328 | 467 | 649 | 102 | 561 | 474 | Upgrade |
Free Cash Flow Per Share | 2.63 | 3.76 | 4.35 | 0.65 | 3.06 | 2.24 | Upgrade |
Dividend Per Share | 0.650 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | Upgrade |
Dividend Growth | -35.00% | - | - | - | - | - | Upgrade |
Gross Margin | 30.00% | 31.51% | 33.60% | 32.62% | 34.14% | 36.34% | Upgrade |
Operating Margin | 0.66% | 1.27% | 4.75% | 3.15% | 5.81% | 4.70% | Upgrade |
Profit Margin | -23.26% | -21.46% | -0.19% | -4.73% | -6.66% | 2.54% | Upgrade |
Free Cash Flow Margin | 5.31% | 7.51% | 9.43% | 1.44% | 7.97% | 6.75% | Upgrade |
EBITDA | 290 | 326 | 541 | 449 | 695 | 656 | Upgrade |
EBITDA Margin | 4.70% | 5.24% | 7.86% | 6.32% | 9.88% | 9.34% | Upgrade |
D&A For EBITDA | 249 | 247 | 214 | 225 | 286 | 326 | Upgrade |
EBIT | 41 | 79 | 327 | 224 | 409 | 330 | Upgrade |
EBIT Margin | 0.66% | 1.27% | 4.75% | 3.15% | 5.81% | 4.70% | Upgrade |
Effective Tax Rate | - | - | - | - | - | 25.00% | Upgrade |
Revenue as Reported | 6,174 | 6,221 | 6,886 | 7,107 | 7,038 | 7,022 | Upgrade |
Updated Jul 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.